Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length

Mark W. Becher, Joyce A. Kotzuk, Alan H. Sharp, Stephen W. Davies, Gillian P. Bates, Donald L. Price, Christopher A Ross

Research output: Contribution to journalArticle

Abstract

Huntington's disease (HD) is caused by CAG triplet repeat expansion in IT15 which leads to polyglutamine stretches in the HD protein product, huntingtin. The pathological hallmark of HD is the degeneration of subsets of neurons, primarily those in the striatum and neocortex. Specific morphological markers of affected cells have not been identified in patients with HD, although a unique intranuclear inclusion was recently reported in neurons of transgenic animals expressing a construct encoding the N-terminal part (including the glutamine repeat) of huntingtin (Davies et al., 1997). In order to understand the importance of this finding, we sought for comparable nuclear abnormalities in autopsy material from patients with HD. In all 20 HD cases examined, anti-ubiquitin and N-terminal huntingtin antibodies identified intranuclear inclusions in neurons and the frequency of these lesions correlated with the length of the CAG repeat in IT15. In addition, examination of material from the related HD-like triplet repeat disorder, dentatorubral and pallidoluysian atrophy, also revealed intranuclear neuronal inclusions. These findings suggest that intranuclear inclusions containing protein aggregates may be a common feature of the pathogenesis of glutamine repeat neurodegenerative disorders.

Original languageEnglish (US)
Pages (from-to)387-397
Number of pages11
JournalNeurobiology of Disease
Volume4
Issue number6
DOIs
StatePublished - Jan 1998

Fingerprint

Progressive Myoclonic Epilepsy
Trinucleotide Repeats
Intranuclear Inclusion Bodies
Huntington Disease
Glutamine
Neurons
Nerve Degeneration
Genetically Modified Animals
Neocortex
Ubiquitin
Neurodegenerative Diseases
Autopsy
Antibodies

ASJC Scopus subject areas

  • Neurology

Cite this

Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy : Correlation between the density of inclusions and IT15 CAG triplet repeat length. / Becher, Mark W.; Kotzuk, Joyce A.; Sharp, Alan H.; Davies, Stephen W.; Bates, Gillian P.; Price, Donald L.; Ross, Christopher A.

In: Neurobiology of Disease, Vol. 4, No. 6, 01.1998, p. 387-397.

Research output: Contribution to journalArticle

Becher, Mark W. ; Kotzuk, Joyce A. ; Sharp, Alan H. ; Davies, Stephen W. ; Bates, Gillian P. ; Price, Donald L. ; Ross, Christopher A. / Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy : Correlation between the density of inclusions and IT15 CAG triplet repeat length. In: Neurobiology of Disease. 1998 ; Vol. 4, No. 6. pp. 387-397.
@article{d715c896a43f41d881275d1c4885a6bc,
title = "Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length",
abstract = "Huntington's disease (HD) is caused by CAG triplet repeat expansion in IT15 which leads to polyglutamine stretches in the HD protein product, huntingtin. The pathological hallmark of HD is the degeneration of subsets of neurons, primarily those in the striatum and neocortex. Specific morphological markers of affected cells have not been identified in patients with HD, although a unique intranuclear inclusion was recently reported in neurons of transgenic animals expressing a construct encoding the N-terminal part (including the glutamine repeat) of huntingtin (Davies et al., 1997). In order to understand the importance of this finding, we sought for comparable nuclear abnormalities in autopsy material from patients with HD. In all 20 HD cases examined, anti-ubiquitin and N-terminal huntingtin antibodies identified intranuclear inclusions in neurons and the frequency of these lesions correlated with the length of the CAG repeat in IT15. In addition, examination of material from the related HD-like triplet repeat disorder, dentatorubral and pallidoluysian atrophy, also revealed intranuclear neuronal inclusions. These findings suggest that intranuclear inclusions containing protein aggregates may be a common feature of the pathogenesis of glutamine repeat neurodegenerative disorders.",
author = "Becher, {Mark W.} and Kotzuk, {Joyce A.} and Sharp, {Alan H.} and Davies, {Stephen W.} and Bates, {Gillian P.} and Price, {Donald L.} and Ross, {Christopher A}",
year = "1998",
month = "1",
doi = "10.1006/nbdi.1998.0168",
language = "English (US)",
volume = "4",
pages = "387--397",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy

T2 - Correlation between the density of inclusions and IT15 CAG triplet repeat length

AU - Becher, Mark W.

AU - Kotzuk, Joyce A.

AU - Sharp, Alan H.

AU - Davies, Stephen W.

AU - Bates, Gillian P.

AU - Price, Donald L.

AU - Ross, Christopher A

PY - 1998/1

Y1 - 1998/1

N2 - Huntington's disease (HD) is caused by CAG triplet repeat expansion in IT15 which leads to polyglutamine stretches in the HD protein product, huntingtin. The pathological hallmark of HD is the degeneration of subsets of neurons, primarily those in the striatum and neocortex. Specific morphological markers of affected cells have not been identified in patients with HD, although a unique intranuclear inclusion was recently reported in neurons of transgenic animals expressing a construct encoding the N-terminal part (including the glutamine repeat) of huntingtin (Davies et al., 1997). In order to understand the importance of this finding, we sought for comparable nuclear abnormalities in autopsy material from patients with HD. In all 20 HD cases examined, anti-ubiquitin and N-terminal huntingtin antibodies identified intranuclear inclusions in neurons and the frequency of these lesions correlated with the length of the CAG repeat in IT15. In addition, examination of material from the related HD-like triplet repeat disorder, dentatorubral and pallidoluysian atrophy, also revealed intranuclear neuronal inclusions. These findings suggest that intranuclear inclusions containing protein aggregates may be a common feature of the pathogenesis of glutamine repeat neurodegenerative disorders.

AB - Huntington's disease (HD) is caused by CAG triplet repeat expansion in IT15 which leads to polyglutamine stretches in the HD protein product, huntingtin. The pathological hallmark of HD is the degeneration of subsets of neurons, primarily those in the striatum and neocortex. Specific morphological markers of affected cells have not been identified in patients with HD, although a unique intranuclear inclusion was recently reported in neurons of transgenic animals expressing a construct encoding the N-terminal part (including the glutamine repeat) of huntingtin (Davies et al., 1997). In order to understand the importance of this finding, we sought for comparable nuclear abnormalities in autopsy material from patients with HD. In all 20 HD cases examined, anti-ubiquitin and N-terminal huntingtin antibodies identified intranuclear inclusions in neurons and the frequency of these lesions correlated with the length of the CAG repeat in IT15. In addition, examination of material from the related HD-like triplet repeat disorder, dentatorubral and pallidoluysian atrophy, also revealed intranuclear neuronal inclusions. These findings suggest that intranuclear inclusions containing protein aggregates may be a common feature of the pathogenesis of glutamine repeat neurodegenerative disorders.

UR - http://www.scopus.com/inward/record.url?scp=0031918640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031918640&partnerID=8YFLogxK

U2 - 10.1006/nbdi.1998.0168

DO - 10.1006/nbdi.1998.0168

M3 - Article

C2 - 9666478

AN - SCOPUS:0031918640

VL - 4

SP - 387

EP - 397

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 6

ER -